by Richard Ingham
Scientists on Thursday said they had a drug that in mice helped prevent prion disease and may also work on Alzheimer's, Parkinson's and other brain disorders that share a similar mechanism.
Still at a very early and experimental stage, the drug blocks disruption of the brain's defence system, something that boosts neurodegenerative disease.
Many of these crippling and tragic diseases start with the buildup of rogue, scrunched-up proteins in the brain.
The organ's response to this is to switch on a defence mechanism called the unfolded protein response, or UPR.
The mechanism orders cells to stop producing new proteins so that the problem is not worsened.
But the buildup of misshapen proteins prevents the UPR mechanism from being switched off.
As a result, the misshapen proteins are no longer made—but nor are normal proteins that are essential for brain-cell survival. Neurons start to die, are not replenished, and the disease progresses.
British researchers, reporting in the US journal Science Translational Medicine, tested a drug that works on a key point in this switching pathway, an enzyme called PERK, to keep protein production open.
Known by its lab name as GSK2606414—it is made by British drugmaker GlaxoSmithKline—the drug was tested on 29 mice with prion disease, a family of disorders that includes Creuzfeldt-Jakob disease.
These were compared against a group of "control" mice, whose brain had also been infected with prions but did not receive the drug.
Mice that were treated seven weeks after being infected with the prions suffered no memory loss in a test to recognise a familiar object, but those treated at nine weeks lost their memory.
This video is not supported by your browser at this time.
The mice were killed and autopsied, and examination of samples under a microscope confirmed that brain-cell death among all the treated mice was very low, although less so among the nine-week group.
The University of Leicester team, say they are hugely buoyed by the success, although many more years of tests lie ahead.
"We were extremely excited when we saw the treatment stop the disease in its tracks and protect brain cells, restoring some normal behaviours and preventing memory loss in the mice," said Giovanna Mallucci, a professor of toxicology.
"We're still a long way from a usable drug for humans - this compound had serious side effects," Mallucci told Britain's Press Association.
"But the fact we have established that this pathway can be manipulated to protect against brain cell loss, first with genetic tools and now with a compound, means that developing drug treatments targeting this pathway for prion and other neurodegenerative diseases is now a real possibility."
If the drug eventually progressed to human patients, people would need treatment "for years or even decades in many cases," the study also cautioned.
In a commentary carried in the same journal, neuroscientists Wiep Scheper and Jeroen Hoozemans of the Free University of Amsterdam said the research may have thrown open "a new therapeutic strategy."
They too urged caution, saying that mouse models designed to replicate human brain disease had limitations, and in humans, loss of the PERK enzyme also had side-effects in promoting diabetes and skeletal defects.
Explore further: Recombinant human prion protein inhibits prion propagation
More information: "An Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice," by J.A. Moreno et al. Science Translational Medicine, 2013.
"A New PERKspective on Neurodegeneration," by W. Scheper et al. Science Translational Medicine, 2013.
© 2013 AFP
Medical Xpress on facebook
Related Stories
Researchers 'switch off' neurodegeneration in mice
May 08, 2012
Researchers at the Medical Research Council (MRC) Toxicology Unit at the University of Leicester have identified a major pathway leading to brain cell death in mice with neurodegenerative disease. The team was able to block ...
Recombinant human prion protein inhibits prion propagation
17 hours ago
Case Western Reserve University researchers today published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers ...
Prion-like proteins drive several diseases of aging
Sep 05, 2013
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
Alzheimer's missing link found
Sep 04, 2013
Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer's disease, they report in the Sept. 4 issue of the journal Neuron. Researchers also f ...
Receptor may aid spread of Alzheimer's and Parkinson's in brain
Aug 23, 2013
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's ...
Recommended for you
Using stem cells to promote nerve regeneration
15 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
15 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
New strategy lets cochlear implant users hear music
15 hours ago
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants—technology that allows deaf and hard of hearing people to comprehend speech—hearing ...
New strategy to treat multiple sclerosis shows promise in mice
16 hours ago
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune ...
Researchers identify likely causes, treatment strategies for systemic scleroderma
16 hours ago
Using mice, lab-grown cells and clues from a related disorder, Johns Hopkins researchers have greatly increased understanding of the causes of systemic sclerosis, showing that a critical culprit is a defect in the way certain ...
Recombinant human prion protein inhibits prion propagation
17 hours ago
Case Western Reserve University researchers today published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers ...
User comments
© Medical Xpress 2011-2013, Phys.org network
by Richard Ingham
Scientists on Thursday said they had a drug that in mice helped prevent prion disease and may also work on Alzheimer's, Parkinson's and other brain disorders that share a similar mechanism.
Still at a very early and experimental stage, the drug blocks disruption of the brain's defence system, something that boosts neurodegenerative disease.
Many of these crippling and tragic diseases start with the buildup of rogue, scrunched-up proteins in the brain.
The organ's response to this is to switch on a defence mechanism called the unfolded protein response, or UPR.
The mechanism orders cells to stop producing new proteins so that the problem is not worsened.
But the buildup of misshapen proteins prevents the UPR mechanism from being switched off.
As a result, the misshapen proteins are no longer made—but nor are normal proteins that are essential for brain-cell survival. Neurons start to die, are not replenished, and the disease progresses.
British researchers, reporting in the US journal Science Translational Medicine, tested a drug that works on a key point in this switching pathway, an enzyme called PERK, to keep protein production open.
Known by its lab name as GSK2606414—it is made by British drugmaker GlaxoSmithKline—the drug was tested on 29 mice with prion disease, a family of disorders that includes Creuzfeldt-Jakob disease.
These were compared against a group of "control" mice, whose brain had also been infected with prions but did not receive the drug.
Mice that were treated seven weeks after being infected with the prions suffered no memory loss in a test to recognise a familiar object, but those treated at nine weeks lost their memory.
This video is not supported by your browser at this time.
The mice were killed and autopsied, and examination of samples under a microscope confirmed that brain-cell death among all the treated mice was very low, although less so among the nine-week group.
The University of Leicester team, say they are hugely buoyed by the success, although many more years of tests lie ahead.
"We were extremely excited when we saw the treatment stop the disease in its tracks and protect brain cells, restoring some normal behaviours and preventing memory loss in the mice," said Giovanna Mallucci, a professor of toxicology.
"We're still a long way from a usable drug for humans - this compound had serious side effects," Mallucci told Britain's Press Association.
"But the fact we have established that this pathway can be manipulated to protect against brain cell loss, first with genetic tools and now with a compound, means that developing drug treatments targeting this pathway for prion and other neurodegenerative diseases is now a real possibility."
If the drug eventually progressed to human patients, people would need treatment "for years or even decades in many cases," the study also cautioned.
In a commentary carried in the same journal, neuroscientists Wiep Scheper and Jeroen Hoozemans of the Free University of Amsterdam said the research may have thrown open "a new therapeutic strategy."
They too urged caution, saying that mouse models designed to replicate human brain disease had limitations, and in humans, loss of the PERK enzyme also had side-effects in promoting diabetes and skeletal defects.
Explore further: Recombinant human prion protein inhibits prion propagation
More information: "An Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice," by J.A. Moreno et al. Science Translational Medicine, 2013.
"A New PERKspective on Neurodegeneration," by W. Scheper et al. Science Translational Medicine, 2013.
© 2013 AFP
Medical Xpress on facebook
Related Stories
Researchers 'switch off' neurodegeneration in mice
May 08, 2012
Researchers at the Medical Research Council (MRC) Toxicology Unit at the University of Leicester have identified a major pathway leading to brain cell death in mice with neurodegenerative disease. The team was able to block ...
Recombinant human prion protein inhibits prion propagation
17 hours ago
Case Western Reserve University researchers today published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers ...
Prion-like proteins drive several diseases of aging
Sep 05, 2013
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
Alzheimer's missing link found
Sep 04, 2013
Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer's disease, they report in the Sept. 4 issue of the journal Neuron. Researchers also f ...
Receptor may aid spread of Alzheimer's and Parkinson's in brain
Aug 23, 2013
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's ...
Recommended for you
Using stem cells to promote nerve regeneration
15 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
15 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
New strategy lets cochlear implant users hear music
15 hours ago
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants—technology that allows deaf and hard of hearing people to comprehend speech—hearing ...
New strategy to treat multiple sclerosis shows promise in mice
16 hours ago
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune ...
Researchers identify likely causes, treatment strategies for systemic scleroderma
16 hours ago
Using mice, lab-grown cells and clues from a related disorder, Johns Hopkins researchers have greatly increased understanding of the causes of systemic sclerosis, showing that a critical culprit is a defect in the way certain ...
Recombinant human prion protein inhibits prion propagation
17 hours ago
Case Western Reserve University researchers today published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment